Therefore, in the present study, we aimed to assess the prevalence of and factors associated with heart failure in patients with EP, and to measure their serum FGF23 concentrations, to determine whether this might represent a useful predictor of chronic heart failure events in patients with EP. This evidence concerns the gene FGF23 and congestive heart failure.